American International Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-671
| Closed | -$18K | – | 3208 |
|
|
2023
Q1 | $18K | Buy |
671
+14
| +2% | +$376 | ﹤0.01% | 2906 |
|
|
2022
Q4 | $23.3K | Sell |
657
-3
| -0.5% | -$106 | ﹤0.01% | 2908 |
|
|
2022
Q3 | $149K | Buy |
660
+21
| +3% | +$4.74K | ﹤0.01% | 2335 |
|
|
2022
Q2 | $121K | Buy |
639
+109
| +21% | +$20.6K | ﹤0.01% | 2480 |
|
|
2022
Q1 | $132K | Sell |
530
-37
| -7% | -$9.22K | ﹤0.01% | 2472 |
|
|
2021
Q4 | $88K | Sell |
567
-17
| -3% | -$2.64K | ﹤0.01% | 2771 |
|
|
2021
Q3 | $117K | Sell |
584
-14
| -2% | -$2.81K | ﹤0.01% | 2734 |
|
|
2021
Q2 | $153 | Buy |
598
+4
| +0.7% | +$1 | ﹤0.01% | 2673 |
|
|
2021
Q1 | $158 | Buy |
594
+1
| +0.2% | – | ﹤0.01% | 2492 |
|
|
2020
Q4 | $219 | Buy |
593
+45
| +8% | +$17 | ﹤0.01% | 2238 |
|
|
2020
Q3 | $134K | Buy |
548
+68
| +14% | +$16.6K | ﹤0.01% | 2366 |
|
|
2020
Q2 | $138K | Buy |
480
+17
| +4% | +$4.89K | ﹤0.01% | 2332 |
|
|
2020
Q1 | $94K | Sell |
463
-26
| -5% | -$5.28K | ﹤0.01% | 2342 |
|
|
2019
Q4 | $219K | Sell |
489
-4
| -0.8% | -$1.79K | ﹤0.01% | 2154 |
|
|
2019
Q3 | $152K | Sell |
493
-4
| -0.8% | -$1.23K | ﹤0.01% | 2360 |
|
|
2019
Q2 | $158K | Buy |
+497
| New | +$158K | ﹤0.01% | 2387 |
|
|
2017
Q2 | – | Sell |
-72
| Closed | -$25K | – | 3131 |
|
|
2017
Q1 | $25K | Buy |
72
+6
| +9% | +$2.08K | ﹤0.01% | 2941 |
|
|
2016
Q4 | $23K | Sell |
66
-1
| -1% | -$348 | ﹤0.01% | 2961 |
|
|
2016
Q3 | $26.7K | Buy |
67
+1
| +2% | +$399 | ﹤0.01% | 2986 |
|
|
2016
Q2 | $39.5K | Buy |
+66
| New | +$39.5K | ﹤0.01% | 2994 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5134 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5094 |
|
|
2015
Q3 | – | Hold |
0
| – | -$252 | – | 5074 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5066 |
|